US_Flag An official website of the United States government Here's how you know

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.


The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

FDA Drug Safety Podcast: FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use

Step Status
Educational Content
Starts On: Fri, 4/12/24: 12:00 AM EDT
Ends On: Sun, 4/11/27: 12:00 AM EDT
Type: Enduring Material
Credits: 0.5
Description: This enduring material focuses on the recent drug safety communication regarding updates to the prescribing information of all opioid pain medications. The presenter will discuss the risks associated with opioid pain medicines and review the specific changes FDA is requiring within the prescribing information.
  • Describe the signs and symptoms of opioid-induced hyperalgesia (OIH).
  • Identify the potential serious risks associated with opioid pain medications.
  • Summarize the changes FDA is requiring to the prescribing information and patient medication guides for opioid pain medications.
  • Explain the actions healthcare providers can take to contribute to the appropriate prescribing and use of opioid pain medicines.
Additional Information: Review the Activity Announcement for additional details: Announcement Form